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Summary
Large scale studies of influenza vaccination in industry have recently been started. The studies are of two types:
(a) Vaccination was offered to a factory and a record maintained of sickness absence of all employees, both the vaccinated volunteers and the nonvolunteers. In five different factories, the average acceptance rate was 42%.
An analysis of the volunteers in one factory indicated that acceptance of vaccination was highest in middle-aged married women and low in younger and older men.
(b) In the Post Office telecommunications branch vaccination was offered to 26,317 employees in eightyeight units in different parts of the country; 42%o of these accepted vaccination. Ninety-eight other units, employing 25,202 employees, are acting as unvaccinated controls. Sickness absence is being recorded in both groups of units.
In both these groups of studies it is aimed to compare the absence experience of the immunized and non-immunized groups for a prolonged period, both when influenza is and is not occurring.
Preliminary findings are presented of the absence figures for January and February 1972, during which time a mild outbreak of influenza occurred, with only a small effect on sickness absence. Vaccinated persons in factories had lower absence rates than the nonvaccinated persons, and telecommunications units in which vaccination was offered experienced lower absence rates with less respiratory absence.
The significance of these findings is discussed.
Introduction
Although influenza vaccine has been available for many years, and despite numbers of studies made in industry (e.g. MRC Report, 1964; Edmondson et al., 1971; Seratai, 1971) , there is still considerable doubt as to whether annual vaccination in industry would reduce sickness sufficiently to warrant the expense of industrial immunization schemes. On the one hand, apart from its effect on the individual and the family, sickness during influenza outbreaks may result in serious industrial disruption. On the other hand, there are doubts about the degree and duration of the protection conferred by the vaccine, and in years in which an outbreak does not occur, even a highly effective vaccine could clearly not materially affect the level of sickness absence. Furthermore, too few employees might accept vaccination for there to be any noticeable effect on absence in a succeeding outbreak.
Assessments of influenza vaccine in industry are difficult to make. The trials must be large because the size of an influenza outbreak cannot be forecast and the attack-rate might be low. It is difficult to persuade large numbers of industrial workers to take part in a fully controlled study with vaccinated and placebo-inoculated groups chosen by random allocation. Industrial concerns, and unions, will often agree only when vaccine is offered to all employees.
Thus, the comparison lies between those who volunteer and those who do not and is open to the objection that those who volunteer may well be dissimilar from those who do not. Such dissimilarities may be associated with differences in their liability to influenza and to sickness absence in general.
However, it is undoubtedly important to determine how influenza vaccine should be used in industry, and the PHLS, in co-operation with industrial organizations and with the Post Office, has begun studies which try to overcome these difficulties and will provide a real measure of the value of influenza vaccine in preventing sickness absence in industry.
The studies are of two types:
(1) Those Figure 2 shows the proportion who accepted vaccination in terms of age, sex and marital status. The number of men in the different age-groups on which the points in Fig. 2 pharmaceutical factory shows that the higher sickness absence among the non-volunteers was consistently observed in men, in married and unmarried women, and in both monthly-paid (office and management) and weekly-paid (production) employees. The difference was also present in all agegroups. As an example, Fig. 4 shows the absence by age-group in the male works employees. It may be seen that a particularly high rate was evident during the outbreak among older men, in whom the response to the offer of vaccination had been poor (see Fig. 2 ). 25, 202 people were employed. In total, the number of employees vaccinated was 11,064-or 4200 of those to whom the offer was made (the same figure as in the five factories). Each unit, both vaccinated and control, prepared a weekly return of the number of new absences and total days lost from sickness, together with an analysis of the medical certificates relating to sickness of more than 3 days' duration.
The returns started at the end of the first week in January 1972 and a preliminary analysis of the returns for the first 8 weeks has been made. Table 3 shows the number of days lost/100 employees in the vaccinated and control units. A difference in favour of the vaccinated units is apparent, becoming smaller in week 6 (week ending 11 February). When the medical certificates received for respiratory illnesses are considered the difference becomes more marked (Table 4 ) and although the amount of respiratory illness was small, in weeks 3, 4 and 5, the number of certificates for respiratory illness was 5000 greater in the non-vaccinated units. On the other hand, the number of non-respiratory medical certificates showed a greater fluctuation and the overall ratio between the vaccinated and control units was 0-98 for the 8 weeks of January and February (Table 5) . Discussion It will not be possible to attempt to draw conclusions from the present studies (neither in those involving groups of vaccinated and non-vaccinated individuals nor those in which whole industrial units are being compared) until more adequate data have been collected concerning absence both during influenza outbreaks and during periods of appreciable duration when no influenza occurs. Nevertheless, the early observations are, perhaps, of some interest.
In the first winter of the present studies serological evidence suggested that about 5000 of the working population possessed a significant level of immunity to the current strain of influenza A virus. The outbreak of influenza that occurred was mild and its A further matter affecting the value of vaccination concerns the nature of the volunteers who come forward. In the pharmaceutical factory the proportion accepting vaccination was greatest among the middle-aged married women-a factory with a high proportion of such employees might benefit from a vaccination campaign more than a factory employing many men in the younger or older age-groups.
In the studies in which absence is compared in individuals who volunteered to accept vaccination and those who did not, absence was found to be lower among the vaccinated. However, towards the end of the outbreak, in the last 2 weeks of February 1972, when absence rates were falling, absence among the immunized employees remained lower than among the unimmunized. There is evidence that absence due to influenza may persist after the outbreak-probably due to complications and aftereffects of the disease (Miller, Pereira & Clark, 1971) , but this winter's influenza was mild and it seems unlikely that this factor alone accounts for the persisting difference. Any assessment of the role of vaccination will depend on the extent to which the two rates come together in the weeks and months after the outbreak-if they come together at all.
When the absence record during the outbreak of the different age-groups was examined (Fig. 4) , absence was particularly marked in older employees, among whom the proportion accepting vaccination was low (Fig. 2) . There may therefore exist groups of employees, reluctant to accept vaccination, with a poor sickness absence-record and who might also be particularly liable to be off sick during an outbreak.
A difference in sickness absence in the vaccinated and non-vaccinated groups during an influenza outbreak could therefore be due to:
(1) the prevention of influenza by vaccination; (2) the placebo effect-i.e. that the act of volunteering and accepting an injection may influence sickness absence. Thus, volunteers who develop influenza may be inclined to dismiss it lightly, provided it is not too severe. Moreover, only a proportion of absence during an outbreak is due to influenza; some must be caused by colds and other respiratory disease and some might well be due to the grasping of a ready excuse to be away ill; (3) that those who volunteer are the sort of people who are less liable to be ill than the remainder of the factory population, perhaps because they are fitter or take more care of themselves, or because they are less inclined to notice mild illness. By continuing the analysis of absence much information on the records of volunteers and nonvolunteers should be obtained, so that an estimate of the importance of the third factor should be possible. The importance of the second factor, i.e. the placebo effect, can only be determined by a controlled trial using a placebo vaccine, and such studies are in progress.
The Post Office investigation, however, is planned to give valid data of the value of offering vaccination to an industrial unit. By taking sufficient units scattered over the country and comparing the experience of vaccinated and non-vaccinated units, the value of offering vaccination should be measurable. Thus, the number of potential volunteers must be very similar in the control units which were not offered vaccination. The preliminary findings indicate that the 'vaccinated' units did have lower sickness absence figures than the unvaccinated units. A measure of the effect of vaccination will again depend on the findings during the period when no influenza is occurring. If the absence rates in the two groups of units remain apart, it will suggest that vaccination had no real effect. If, on the other hand, the rates come together, it should be possible to suggest that the difference observed during the outbreak is due to vaccination. Whilst it might be argued that an offer of an inert vaccine could have accounted for any effect observed, it is nevertheless true that good evidence exists that influenza vaccine is protective (Eickhoff, 1971) and, moreover, the effect of vaccine in an industrial concern will inevitably include any placebo effect and in estimating the value of vaccination to the management of an industrial concern it is necessary to consider the overall effect of the vaccination campaign.
